Case report of amniotic fluid embolism coagulopathy following abortion; use of viscoelastic point-of-care analysis.
Abortion
Amniotic fluid embolism
Case report
Coagulopathy
Thromboelastography
Viscoelastic point-of-care analysis
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
03 Jan 2020
03 Jan 2020
Historique:
received:
03
11
2018
accepted:
16
12
2019
entrez:
5
1
2020
pubmed:
5
1
2020
medline:
24
10
2020
Statut:
epublish
Résumé
Amniotic fluid embolism (AFE) is a rare, life threatening obstetric complication, often associated with severe coagulopathy. Induced abortions are extremely safe procedures however complications including AFE can occur. A 29-year-old previously healthy woman, gravida 1 para 0, presented for a scheduled second trimester induced abortion via dilation and evacuation at 22-weeks gestation. The case was complicated by a suspected AFE with associated profound coagulopathy. Viscoelastic point-of-care coagulation analysis was used to successfully and swiftly guide management of her coagulopathy. AFE can occur in the setting of induced abortion. This case report suggests viscoelastic point-of-care coagulation analyzers may aid in the management of pregnancy-related coagulopathy by providing faster coagulation assessment than laboratory testing, and facilitating timely, targeted management of coagulopathy.
Sections du résumé
BACKGROUND
BACKGROUND
Amniotic fluid embolism (AFE) is a rare, life threatening obstetric complication, often associated with severe coagulopathy. Induced abortions are extremely safe procedures however complications including AFE can occur.
CASE PRESENTATION
METHODS
A 29-year-old previously healthy woman, gravida 1 para 0, presented for a scheduled second trimester induced abortion via dilation and evacuation at 22-weeks gestation. The case was complicated by a suspected AFE with associated profound coagulopathy. Viscoelastic point-of-care coagulation analysis was used to successfully and swiftly guide management of her coagulopathy.
CONCLUSION
CONCLUSIONS
AFE can occur in the setting of induced abortion. This case report suggests viscoelastic point-of-care coagulation analyzers may aid in the management of pregnancy-related coagulopathy by providing faster coagulation assessment than laboratory testing, and facilitating timely, targeted management of coagulopathy.
Identifiants
pubmed: 31900130
doi: 10.1186/s12884-019-2680-1
pii: 10.1186/s12884-019-2680-1
pmc: PMC6942409
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9Références
Obstet Gynecol. 2017 Aug;130(2):366-373
pubmed: 28697109
Int J Obstet Anesth. 2012 Apr;21(2):202-3
pubmed: 22405979
Am J Obstet Gynecol. 1995 Apr;172(4 Pt 1):1158-67; discussion 1167-9
pubmed: 7726251
Obstet Gynecol. 1994 May;83(5 Pt 2):851-4
pubmed: 8159374
Br J Anaesth. 2012 Dec;109(6):851-63
pubmed: 23075633
Prenat Diagn. 2003 Nov;23(11):950-1
pubmed: 14634988
Obstet Gynecol. 2014 Feb;123(2 Pt 1):337-48
pubmed: 24402585
Crit Care Med. 2012 Jul;40(7):2059-63
pubmed: 22584758
Anesth Analg. 2008 May;106(5):1366-75
pubmed: 18420846
BJOG. 2009 Jul;116(8):1097-102
pubmed: 19459866
Obstet Gynecol. 2015 Aug;126(2):258-65
pubmed: 26241413
Am J Obstet Gynecol. 1990 Apr;162(4):986-90
pubmed: 2327467
Can J Anaesth. 2016 Jul;63(7):871-4
pubmed: 26883961
Am J Obstet Gynecol. 2016 Aug;215(2):B16-24
pubmed: 26987420
Blood Coagul Fibrinolysis. 2010 Jan;21(1):95-100
pubmed: 20040855
Curr Opin Anaesthesiol. 2015 Jun;28(3):275-84
pubmed: 25812005
Int J Obstet Anesth. 2019 May;38:127-130
pubmed: 30279053